NCT05198388|UnknownDMC
Loading search results
Sponsor study identifier
observational
90
1 country
1
Study Start
March 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
March 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Measurement of Beta endorphins,interleukin 1 and interleukin 38 in covid patients associated with neuropsychological manifestations.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 19, 2022
Actual (reported)January 20, 2022
Actual (reported)March 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
- Detection of βeta endorphins, interleukin 6 and interleukin 38 in serum of COVID-19 patients.
\- Detection of βeta endorphins, interleukin 6 and interleukin 38 in serum of COVID-19 patients.
3 years
* \- Collection of peripheral blood samples in gel tube. * \- Creparation of samples in centrifuge to obtain serum. * \- Measurement of interleukin 6 and interleukin 38 and βeta endorphins using ELISA method.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Sixity patients diagnosed with Covid-19 (30 patients with neurological manifestations and 30 patients without neurological manifestations) 30 healthy individuals as control group with matched age and sex.
Contact the study team to confirm eligibility.
Assiut university
Asyut, Egypt
serum sample
First Submitted
January 19, 2022
First Posted
January 20, 2022
Study Start
March 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
March 30, 2024
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 25, 2022
Record last verified: 2022-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: